Management of patients with rheumatoid arthritis by telemedicine: connected monitoring. A randomized controlled trial

Nationwide, large-scale implementation of an online system for remote entry of patient-reported outcomes in rheumatology: characteristics of users and non-users and time to first entry

“…Concepts such as ‘open consultations’ and ‘on-demand access’ have previously been suggested to optimise and tailor timing of consultations in accordance with the patient’s needs—instead of routinely scheduling consults with regular intervals 8. Digital health solutions including video consultations, email correspondence and telephone consultations are examples of contact forms often used as an alternative to physical consultations, depending on preferences and the infrastructure available 7–9 37. There is no doubt that the pandemic further motivated these discussions 38 39…”

“…2 RMD Open RMD Open RMD Open monitoring of diseases constitute a more recent solution. [9][10][11][12][13][14] Recent 2022 EULAR points to consider for remote care in rheumatology highlighted that knowledge about drivers and barriers to telehealth is essential to facilitate remote care approaches in clinical practice. 15 Importantly, not all patients have access, skills or interest in using remote digital solutions.…”

“…The benefits of using patient-reported outcomes (PROs) for monitoring of health status in chronic diseases, including inflammatory rheumatic diseases (IRDs), are well established 1–6. In the debate on how to optimally manage patients with chronic diseases in routine care,7 8 digital solutions for online monitoring of diseases constitute a more recent solution 9–14. Recent 2022 EULAR points to consider for remote care in rheumatology highlighted that knowledge about drivers and barriers to telehealth is essential to facilitate remote care approaches in clinical practice 15.…”

A platform‐based approach to assisting rheumatoid arthritis management

“…Third, adaptation of the treatment plan is enhanced with remote monitoring and resources for decision support. A study has shown the relevance of connected monitoring following the initiation of disease‐modifying antirheumatic drug therapy with an impact on quality of life while reducing the number of consultations 13 . Platforms aim to optimize the treatment using reliable data for evidence‐based decisions.…”

Telemedicine and rheumatology

“…In this issue of the journal, Bernard and colleagues [1] have studied in an open-label, randomized, prospective, monocentric, clinical trial, the cost-effectiveness of connected monitoring utilizing a digital smartphone application plus clinical case manager compared with conventional DMARD therapeutic monitoring in a group of RA patients commencing a DMARD. Sufficient understanding to perform the measures on a smartphone correctly was a requirement.…”